Clinical Trials in Dallas

Showing 3981-4000 of 17,468 trials

A Multicenter Pragmatic Implementation Study of ECG-AI-Based Clinical Decision Support Software to Identify Low LVEF

NCT05867407

A prospective, cluster-randomized, care-as-usual controlled trial to evaluate the impact of an ECG-based artificial intelligence (ECG-AI) algorithm to detect low left ventricular ejection fraction (LVEF) on diagnosis rates of LVEF ≤ 40% in the outpatient setting. The objective of this study is to evaluate the impacts of an ECG-AI algorithm to detect low LVEF and an associated Medical Device Data System when used during routine outpatient care. The study will be conducted in 2 phases: feasibility assessment phase and clinical impact phase.

Ventricular Ejection Fraction

Anumana, Inc.11,610 participantsStarted Jun 2024

Phoenix, Arizona, United States • Jacksonville, Florida, United States • Rochester, Minnesota, United States +2 more locations

COMPLETEDPhase 3< 1 mile

A 12-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Osteoarthritis Pain of the Knee

NCT04683627

A 12-week, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 study to Evaluate the Efficacy and Safety of HP-5000 in Subjects with Osteoarthritis (OA) Pain of the Knee

Osteoarthritis Pain of the Knee

Noven Pharmaceuticals, Inc.370 participantsStarted Dec 2020

Little Rock, Arkansas, United States • Clearwater, Florida, United States • Doral, Florida, United States +7 more locations

A Multicenter Pragmatic Implementation Study of ECG-AI-Based Clinical Decision Support Software to Identify Low LVEF

A 12-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Osteoarthritis Pain of the Knee

Find Trials by Condition in Dallas

Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy Trial

A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine

A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004).

To Assess the Safety, Tolerability and Efficacy of Itacitinib Immediate Release Tablets in Participants With Primary or Secondary Myelofibrosis Who Have Received Prior Ruxolitinib and/or Fedratinib Monotherapy (LIMBER-213)

Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)

A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer

Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention

Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma

Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women

A Study of Abemaciclib in Recurrent Glioblastoma

Saroglitazar Magnesium 4 mg for Nonalcoholic Fatty Liver Disease (NAFLD) in People Living With HIV in the US

A Study to Test Whether Two Different Doses of Avenciguat Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)

The Care Ecosystem Consortium Effectiveness Study

Open-Label Extension Study of Setmelanotide

HIV/STD Risk and PrEP Implementation Messaging Among Gay, Bisexual, and Other Men Who Have Sex With Men

INSPIRIS RESILIA Aortic Valve, Valve-in-Valve Surveillance Study

JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations

Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM